PVR and breast carcinoma: However, since only KIR2DL5A*001 is known to be expressed on the cell membrane (Cisneros et al., 2012), its interaction with its PVR ligands indicates that this KIR2DL5 allotype may be responsible for the predisposition to breast cancer.